본문으로 바로가기
현재 위치:
Home
진료과
외과(유방암ㆍ갑상선암센터)
임우성
관심콘텐츠
프린트

의료진 소개

진료과 의료진
임우성 의사

임우성 교수


외과(유방암ㆍ갑상선암센터), 유방암센터 관심의료진 등록

전문 진료 분야

유방암 ※유방암으로 진단 받은 경우에만 진료 가능합니다.

진료 일정

진료예약 간편 예약 고맙습니다

학력 및 경력사항

학력사항

  • 서울대학교 의과대학 의학과, 의학박사
  • 서울대학교 의과대학 의학과, 의학석사
  • 서울대학교 의과대학 의학과, 의학사

교육 및 연구경력

  • 현재  | 이대여성암병원 유방암·갑상선암센터장
  • 현재  | 이대목동병원 외과 부교수
  • 2009-2010  | 서울아산병원 외과 임상조교수
  • 2007-2009  | 서울아산병원 외과 전임의
  • 2004-2007  | 공중보건의사(충북 음성중앙성심병원 외과 과장)
  • 2000-2004  | 서울대학교병원, 외과 레지던트
  • 1999-2000  | 서울대학교병원, 인턴

기타 학술 관련 경력

  • 2004  | 대한외과학회 회원
  • 2007  | 한국유방암학회 평생회원
  • 2008  | 이승규교수 외과 발전기금상
  • 2008  | 서울아산병원 외과 최우수 전임의상
  • 2008  | 서울대학교 의과대학 외과학교실 젊은 연구자상

논문

  •  Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study.  Scientific Reports. 2022, v.12 no.1, 10729. 
  •  No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.  BMC Cancer. 2022, v.22 no.1, 189. 
  •  Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?.  Cancers. 2022, v.14 no.17, 4141. 
  •  Staphylococcus aureus-Derived Extracellular Vesicles Enhance the Efficacy of Endocrine Therapy in Breast Cancer Cells.  Journal of Clinical Medicine. 2022, v.11 no.7, 2030. 
  •  Accuracy of Digital Breast Tomosynthesis for Detecting Breast Cancer in the Diagnostic Setting: A Systematic Review and Meta.  KOREAN JOURNAL OF RADIOLOGY. 2021, v.22 no.8, 1240-1252. 
  •  Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells.  Medicine. 2021, v.100 no.18, e25835. 
  •  Efficacy of erector spinae plane block with opioid-sparing analgesic technique in breast-conserving surgery.  Annals of Surgical Treatment and Research. 2021, v.100 no.5, 253-259. 
  •  Feasibility and safety of breast-conserving surgery via a periareolar incision for cancers located far from the nipple–areolar complex: a retrospective study.  Journal of Cancer Research and Clinical Oncology. 2021, v.147 no.3, 893-900. 
  •  Impact of 18F-FDG PET on the management of recurrent breast cancer: a meta-analysis.  Clinical and Translational Imaging. 2021, v.9 no.3, 255-263. 
  •  Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study.  BMC Cancer. 2021, v.21 no.1, 647. 
  •  Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1.  PLOS ONE. 2021, v.16 no.9, e0257298. 
  •  The comparison of breast reconstruction using two types of acellular dermal matrix after breast-conserving surgery.  Journal of Clinical Medicine. 2021, v.10 no.15, 3430. 
  •  Nipple-sparing mastectomy through periareolar incision with immediate reconstruction.  ANNALS OF SURGICAL TREATMENT AND RESEARCH. 2020, v.98 no.2, 57-61. 
  •  Pleural Schwannoma Suspected as Metastasis of Breast Cancer.  The American journal of case reports. 2020, v.21, e921548. 
  •  Pure hemi-periareolar incision versus conventional lateral radial incision mastectomy and direct-to-implant breast reconstructions: comparison of indocyanine green angiographic perfusion and necrosis of the nipple.  GLAND SURGERY. 2020, v.9 no.5, 1193-1204. 
  •  Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.  IN VIVO. 2020, v.34 no.1, 185-190. 
  •  Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study.  JOURNAL OF BREAST CANCER. 2019, v.22 no.1, 29-37. 
  •  Correction: 33rd Annual meeting & pre-conference programs of the Society for Immunotherapy of Cancer (SITC 2018) (Journal for ImmunoTherapy of Cancer (2018) 6:Suppl 1 DOI: 10.1186/s40425-018-0422-y).  Journal for ImmunoTherapy of Cancer. 2019, v.7 no.1, 46. 
  •  Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma.  JOURNAL OF BREAST CANCER. 2019, v.22 no.3, 484-490. 
  •  Increased risk of postoperative complications after total thyroidectomy with Graves' disease.  Head and Neck. 2019, v.41 no.2, 281-285. 
  •  Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis.  Breast Cancer Research and Treatment. 2019, v.178 no.3, 693-701. 
  •  Physiologic intestinal F-18-FDG uptake is associated with alteration of gut microbiota and proinflammatory cytokine levels in breast cancer.  SCIENTIFIC REPORTS. 2019, v.9, 18273. 
  •  Quantitative Assessment of the Learning Curve for Robotic Thyroid Surgery.  JOURNAL OF CLINICAL MEDICINE. 2019, v.8 no.3, 402. 
  •  Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.  Breast Cancer. 2019, v.26 no.4, 510-519. 
  •  Routine low-dose calcium supplementation after thyroidectomy does not reduce the rate of symptomatic hypocalcemia: A prospective randomized trial.  Annals of Surgical Treatment and Research. 2019, v.96 no.4, 177-184. 
  •  Spindle Cell Sarcoma Mimicking Supraclavicular Lymph Node Metastasis of Breast Cancer.  The American journal of case reports. 2019, v.20, 194-197. 
  •  The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry.  BREAST CANCER RESEARCH AND TREATMENT. 2019, v.177 no.3, 669-678. 
  •  Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.  BREAST CANCER RESEARCH AND TREATMENT. 2018, v.172 no.2, 437-444. 
  •  Efficacy of a clinical pathway for patients with thyroid cancer.  HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2018, v.40 no.9, 1909-1916. 
  •  Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.  CLINICAL BREAST CANCER. 2018, v.18 no.5, E1123-E1132. 
  •  Gastric metastasis as the first presentation one year before diagnosis of primary breast cancer.  American Journal of Case Reports. 2018, v.19, 354-359. 
  •  Basic Facts of Breast Cancer in Korea in 2014:The 10-Year Overall Survival Progress.  JOURNAL OF BREAST CANCER. 2017, v.20 no.1, 1-11. 
  •  Endoscopic Thyroidectomy Via the Cervico-axillary Approach for Thyroid Cancer: Initial Experience in a Single Institute.  The Journal of Endocrine Surgery. 2017, v.17 no.1, 19~24. 
  •  Percentage Decline of Parathyroid Hormone Level is a Predictor for Post-thyroidectomy Symptomatic Hypocalcemia.  The Journal of Endocrine Surgery. 2017, v.17 no.4, 168~174. 
  •  Strong correlation of indoleamine 2,3-dioxygenase 1 expression with basal-like phenotype and increased lymphocytic infiltration in triple-negative breast cancer.  Journal of Cancer. 2017, v.8 no.1, 124-130. 
  •  A lectin-based approach to detecting carcinogenesis in breast tissue.  ONCOLOGY LETTERS. 2016, v.11 no.6, 3889-3895. 
  •  Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer.  Human Pathology. 2016, v.55, 190-195. 
  •  Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer.  ANTICANCER RESEARCH. 2016, v.36 no.9, 4847-4851. 
  •  Combinatorial TGF-beta attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.  ONCOTARGET. 2015, v.6 no.35, 37535-37552. 
  •  Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.  BMC Cancer. 2015, v.15 no.1. 
  •  Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study.  JOURNAL OF BREAST CANCER. 2015, v.18 no.1, 8-15. 
  •  TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling.  Scientific Reports. 2015, v.5. 
  •  The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean.  Breast Cancer. 2015, 21 JUL 2015. 
  •  Attenuation of experimental colitis in glutathione peroxidase 1 and catalase double knockout mice through enhancing regulatory T cell function.  PLoS ONE. 2014, v.9 no.4. 
  •  Immune Enhancing Effects of Echinacea purpurea Root Extract by Reducing Regulatory T Cell Number and Function.  NATURAL PRODUCT COMMUNICATIONS. 2014, v.9 no.4, 511-514. 
  •  Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).  BMC CANCER. 2014, v.14, Article ID 170. 
  •  Prognostic Value of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1) Expression in Breast Cancer.  PLOS ONE. 2014, v.9 no.6. 
  •  Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function.  PLOS ONE. 2014, v.9 no.3, Article ID e91146. 
  •  Zonal Difference and Prognostic Significance of Foxp3 RegulatoryT Cell Infiltration in Breast Cancer.  JOURNAL OF BREAST CANCER. 2014, v.17 no.1, 8-17. 

저서

  • 유방암 환자를 위한 치료안내서 3판, 공동저자

    |